Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.
Key Details
- 1REDMOD is an AI radiomics model for detecting subtle texture changes indicative of stage 0 pancreatic ductal adenocarcinoma on CT.
- 2The model identified preclinical disease an average of 475 days before clinical diagnosis.
- 3In head-to-head comparison, REDMOD's sensitivity was nearly double that of expert radiologists (73% vs. 39%).
- 4Performance remained high (68% vs. 23%) for cancers detected over two years before diagnosis.
- 5The model showed strong generalisability in external cohorts (correctly identifying >81% and 87.5% of cases in independent datasets).
- 6Researchers caution further prospective validation and testing in high-risk patients are needed before clinical adoption.
Why It Matters
Ultra-early detection of pancreatic cancer could dramatically improve survival rates by enabling treatment before symptoms arise. AI models like REDMOD may soon provide radiologists with powerful new tools to catch deadly cancers in their most treatable phases.
Source
EurekAlert
Related News
•EurekAlert
Peking University Debuts LargePNet for Superior Fluorescence Image Restoration
Peking University's Xi Peng lab introduces LargePNet, a new AI for robust fluorescence image restoration, outperforming patch-based methods.
•EurekAlert
AI Detects Smuggled Marine Life in Airport CT Scans
Researchers developed an AI algorithm to identify smuggled marine wildlife in airport luggage using CT scans with high accuracy.
•EurekAlert
AI Predicts Brain Tumor Risks from Routine Pathology Slides
Mayo Clinic developed an AI that analyzes routine pathology slides to classify meningiomas and predict recurrence risk, reducing dependency on advanced genetic testing.